Prosensa
Acquired
- Headquarters
- Leiden
- Employees
- 51–200
- Founded
- 2002
- Business Model
- B2B
- Website
- prosensa.eu
- Total Funding
- $30.0M
- Last Round
- $30.0M Series CJan 2012
About
Prosensa was a Leiden, Netherlands-based biopharmaceutical company focused on the discovery, development, and commercialization of RNA-modulating therapeutics for rare neuromuscular diseases, particularly Duchenne muscular dystrophy. Founded in 2002, the company went public before being acquired by BioMarin Pharmaceutical in 2014 for approximately $680 million.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account